Pyxis Oncology, Inc. (PYXS) stock
PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.58+0.00 (0.00%)
Close on Nov 13, 2026Market cap $131.79MP/E –Yield –
Pyxis Oncology operating margin
Operating margin is operating income as a percentage of revenue.
Pyxis Oncology's operating margin for the twelve months ending Dec 31, 2025 was -609.2%. For fiscal 2025 it was -609.2%, against -554.1% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -609.2% | −55.1 |
| FY2024 | Dec 31, 2024 | -554.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -165.7% | – |
| Q2 FY2025 | Jun 30, 2025 | -700.4% | – |
| Q1 FY2024 | Mar 31, 2024 | -34.7% | – |
See a number that looks wrong?